Patient info Open main menu

Evrysdi® 5 mg – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) ▼ Additional monitoring Details

Medicine strength:
5 mg
Contains active substance:
ATC code:
Similar medicines:

Patient leaflet - Evrysdi 5 mg film-coated tablets

1. What Evrysdi is and what it is used for

Evrysdi contains the active substance risdiplam. It is part of a group of medicines known as ‘pre-mRNA splicing modifiers’.

Evrysdi is used to treat spinal muscular atrophy (SMA) in adults and children.

  • SMA is an illness that runs in families – a genetic illness. ● It is caused by a shortage of a protein called ‘survival motor neuron’

    (SMN) in the body.

If you do not have enough SMN protein, you lose motor neurons. Motor neurons are nerve cells that control muscles.

  • This leads to muscle weakness and wasting.
  • This can make everyday movements difficult, such as head and

    neck control, sitting, crawling and walking.

  • The muscles used for breathing and swallowing may also become

    weaker.

How Evrysdi works

Evrysdi works by helping the body produce more SMN protein. ● This means you lose fewer motor neurons – this may improve how

well muscles work in people with SMA.

In infants with SMA Type 1, Evrysdi may:

  • increase how long they live
  • reduce the need for a ventilator to help with breathing ● help them be able to keep being fed by mouth.

In children (toddlers to adolescents) and adults with SMA Type 2 and 3, Evrysdi may:

  • stop muscle control getting worse
  • improve muscle control.

2. What you need to know before you take Evrysdi

Do not take Evrysdi:

  • if you are allergic to risdiplam or any of the other ingredients of this

    medicine (listed in section 6).

If you are not sure, talk to your doctor, pharmacist, or nurse before you take Evrysdi.

Warnings and precautions

Talk to your doctor, pharmacist, or nurse before you take Evrysdi.

Treatment with Evrysdi may harm your unborn baby or may affect male fertility. See “Pregnancy”, “Contraception”, and “Male fertility” for more information.

Other medicines and Evrysdi

Tell your doctor, pharmacist, or nurse if you are taking, have recently taken or might take any other medicines in the future.

In particular tell your doctor, pharmacist, or nurse if you are taking or have ever taken any of the following medicines:

  • metformin – a medicine used to treat type 2 diabetes ● medicines for the treatment of SMA

Pregnancy

Before you start treatment with this medicine, your doctor should do a pregnancy test. This is because Evrysdi may harm your unborn baby. ● Do not take this medicine if you are pregnant.

  • Do not become pregnant:

    • during your treatment with Evrysdi and
    • for one month after you stop taking Evrysdi.

If you do become pregnant during your treatment, tell your doctor straight away. You and your doctor will decide what is best for you and your unborn baby.

Contraception

For women

You must use a highly effective method of birth control: ● while taking this medicine and

  • for one month after you stop taking this medicine.

Talk to your doctor about highly effective methods of birth control that you and your partner can use.

For men

If your partner is a woman who can have children, she must not become pregnant.

Use condoms:

  • while taking this medicine and
  • for 4 months after you stop taking this medicine.

Talk to your doctor about highly effective methods of birth control that you and your partner can use.

Breast-feeding

Do not breast-feed while taking this medicine. This medicine may pass into breast milk and may harm your baby.

Talk to your doctor about whether you should stop breast-feeding or if you should stop taking Evrysdi.

Male fertility

Evrysdi may reduce male fertility during treatment and for up to 4 months after your last dose.

  • If you are planning to have a child, ask your doctor for advice. ● Do not donate sperm during your treatment and for 4 months after

    your last dose of this medicine.

Driving and using machines

This medicine is unlikely to affect your ability to drive and use machines.

Evrysdi contains sodium

Evrysdi contains a small amount of sodium (salt) - there is less than 1 mmol (23 mg) sodium. This means it is essentially ‘sodium-free’ and can be used by people on a sodium-restricted diet.

3. How to take Evrysdi

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

You will get blister packs of Evrysdi as film-coated tablets, referred to as a ‘tablet’ in this leaflet. This medicine is also available as an oral solution. Your doctor will help you choose the right one for you.

How much Evrysdi to take

If you get Evrysdi film-coated tablets, the dose is 5 mg (one tablet) once daily.

You must take your daily dose as instructed by your doctor. ● Do not change the dose without speaking with your doctor.

When and how to take Evrysdi

Read the ‘Instructions for Use’ at the end of this leaflet. Follow the instructions carefully. It shows you exactly how to make and take Evrysdi as a mixture.

T ake Evrysdi:

  • once a day, at around the same time - this will help you remember

    when to take your medicine

  • with or without food.

There are two ways your doctor may tell you to take Evrysdi film-coated tablets:

  • Take Evrysdi by mouth. Swallow each tablet whole with some

    water.

    • Do not cut, crush or chew the tablets.

Or

  • Take Evrysdi by mouth after dispersing it in a small amount of room

    temperature water.

    • Do not mix Evrysdi with any liquids other than water.
    • Take Evrysdi tablet straight away after mixing with water.

      If you do not take it within 10 minutes of adding water, throw the mixture away and make a new dose.

    • Do not expose the tablet mixture prepared from the Evrysdi

      tablet to sunlight.

    • Do not get Evrysdi tablet mixture on your skin or in your eyes.

      If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water.

    • Do not administer the tablet mixture via a feeding tube.

How long to take Evrysdi for

Your doctor will tell you how long you need to take Evrysdi for. Do not stop treatment with Evrysdi unless your doctor tells you to.

If you take more Evrysdi than you should

If you take more Evrysdi than you should, talk to a doctor or go to hospital straight away.

  • Take the medicine pack and this leaflet with you.

If you forget to take Evrysdi or vomit after a dose

If you forget to take a dose:

  • If it is less than 6 hours after you normally take Evrysdi - take the

    missed dose as soon as you remember.

  • If it is over 6 hours from when you normally take Evrysdi - skip the

    missed dose and then take your next dose at the usual time. Do not take a double dose to make up for a forgotten dose. If you are sick (vomit) after taking Evrysdi:

  • Do not take an extra dose. Instead, take the next dose at the usual

    time the next day.

    If you spill Evrysdi

    If you spill Evrysdi tablet mixture, dry the area with a dry paper towel and then clean the area with soap and water. Throw away the paper towel in the rubbish and wash your hands well with soap and water.

    If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Very common: may affect more than 1 in 10 people ● diarrhoea

  • rash
  • headache
  • fever

Common: may affect up to 1 in 10 people

  • feeling sick (nausea)
  • mouth sores
  • bladder infection
  • joint pain

Not known: it is not known how often these happen ● inflamed small blood vessels mainly in the skin (cutaneous

vasculitis)

Reporting of side effects

If you or your child get any side effects, talk to your doctor or pharmacist or nurse. This includes any

possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow

Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the

Google Play or Apple App Store. By reporting side effects you can help provide more information on

the safety of this medicine.

5. How to store Evrysdi

  • Keep this medicine out of the sight and reach of children. ● This medicinal product does not require any special temperature

    storage conditions.

  • Store in the original package in order to protect from moisture.

Do not use this medicine after the expiry date which is stated on the carton and the blister after EXP. The expiry date refers to the last day of that month.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Evrysdi contains

  • The active substance in the film-coated tablet is risdiplam. ● Each film-coated tablet contains 5 mg risdiplam.
  • The other ingredients are tartaric acid (E 334), mannitol (E 421),

    microcrystalline cellulose, silica, colloidal anhydrous (E 551), crospovidone, strawberry flavour [natural flavouring substance(s), flavouring preparation(s), maize maltodextrin, modified waxy maize starch (E1450)] and sodium stearyl fumarate, polyvinyl alcohol, titanium dioxide (E 171), macrogol 3350 (E 1521), talc (E 553b) and yellow iron oxide (E 172).

What Evrysdi looks like and contents of the pack

  • Evrysdi tablets are pale yellow film-coated tablets, round and

    curved, with EVR debossed on one side.

  • Evrysdi is supplied in packs containing 28 x 1 film-coated tablets.

    There are 4 aluminium perforated unit-dose blisters with 7 tablets each.

    • The blisters strips are each marked with abbreviated names of

      the day as a reminder to take a daily dose:

      Mon. Tue. Wed. Thu. Fri. Sat. Sun

Marketing Authorisation Holder

Roche Products Limited

6 Falcon Way, Shire Park

Welwyn Garden City

AL7 1TW

United Kingdom

This leaflet was last revised in February 2026.

Instructions for Use – Administration

Evrysdi film coated tablets

This Instructions for Use contains information on how to prepare and take Evrysdi.

  • The information in this Instructions for Use is for taking or giving this medicine – but here we just say ‘take’.

Before you start

Read this Instructions for Use before taking Evrysdi film-coated tablets for the first time and each time you get a refill. There may be new information.

Evrysdi film-coated tablets can be swallowed whole or mixed with a small amount of room temperature water and taken by mouth.

Do not give Evrysdi film-coated tablets with a feeding tube.

Important Information

  • Your doctor, pharmacist, or nurse will show you how to prepare and take Evrysdi tablets. Always take Evrysdi tablets exactly as your healthcare provider tells you.
  • Do not take or give this medicine until you have been shown how to properly prepare and take Evrysdi.
  • Wash your hands before and after preparing or taking Evrysdi. ● Check the expiry date and check the product for damage before use. Do not use if expired or damaged.
  • Do not get the Evrysdi tablet mixture on your skin or in your eyes.

    If the Evrysdi tablet mixture gets on your skin, wash the area with soap and water. If the tablet mixture gets in your eyes, rinse your eyes with water.

  • Keep the Evrysdi tablet mixture out of sunlight.
  • If you spill the Evrysdi tablet mixture, dry the area with a dry paper towel and then clean with soap and water. Throw away the paper towel in the rubbish and wash your hands with soap and water.

How to take Evrysdi tablets

  • If you are taking Evrysdi tablets, the daily dose is 1 tablet. ● Take the tablet whole with water or as a liquid by mixing 1 tablet in at least 1 teaspoon (5 ml) of room temperature water. ● Do not chew, cut, or crush the tablet.
  • Do not mix Evrysdi with any liquids other than water. ● Do not take Evrysdi tablet mixture if it has been more than

    10 minutes since adding water to the tablet. Throw the mixture away according to your local requirements and make a new dose. ● Do not take an extra dose if you are sick (vomit) at any time after taking Evrysdi.

Get ready to take an Evrysdi tablet
Step 1. Wash your hands. (Figure A).Figure A
Step 2. Take out 1 Evrysdi tablet from the blister (Figure B).Figure B

Option A: Swallow the Evrysdi tablet whole

Step A1

Swallow the tablet whole with some water. Do not chew, cut, or crush the tablet

Do not swallow with any liquids other than water.

Step A2

Wash your hands with soap and water.

Option B: Take Evrysdi tablet mixed in water

What is needed to mix Evrysdi with water:

  • 1 Evrysdi tablet
  • a small, clean empty cup
  • at least 1 teaspoon (5ml) of room temperature water for mixing ● at least 1 tablespoon (15ml) of water for rinsing

Step B1

Put at least 1 teaspoon (5ml) of water in a cup – and add 1 tablet.

  • Do not use any liquids other than water,
  • Keep the mixture out of sunlight.
Figure C

Step B2

Gently swirl the cup until it is fully mixed - this can take up to 3 minutes (Figure C).

Step B3

Drink immediately within 10 minutes of adding water to the tablet (Figure D).

Figure D

Step B4

Refill the cup with at least 1 tablespoon (15ml) of water and swirl to get any medicine left in the cup (Figure E).

Figure E

Step B5

Drink immediately (Figure F).

Figure F

Step B6

Wash your hands with soap and water.

Storing EVRYSDI

  • This medicinal product does not require any special temperature storage conditions.
  • Store in the original package in order to protect from moisture. ● Keep Evrysdi and all medicines out of the sight and reach of children.

    11043697 GB

11043697

LEAF EVRYSDI 5MG TAFI GB

Version 2
Type size:9 pt

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 00031/0945

Last revision stated in the text: February 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Evrysdi 5 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Risdiplam
Strength 5 mg
Pharmaceutical form Oral tablet
How is it taken Oral
Pack sizes 28 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. M Musculo-skeletal system drugs
    1. M09 Other drugs for disorders of the musculo-skeletal system
      1. M09A Other drugs for disorders of the musculo-skeletal system
        1. M09AX Other drugs for disorders of the musculo-skeletal system
          1. M09AX10 risdiplam
Additional monitoring Yes ▼ – new safety information is collected quickly. Report any side effect to the Yellow Card scheme.
Marketing authorisation PL 00031/0945
Codes GTIN 7613326078412

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.